430
Views
16
CrossRef citations to date
0
Altmetric
Original Articles

Apple Polysaccharide Reduces Nf-Kb Mediated Colitis-Associated Colon Carcinogenesis

, , , , , , , , , , & show all
Pages 177-190 | Received 24 May 2014, Accepted 17 Aug 2014, Published online: 20 Nov 2014

REFERENCES

  • Bansal P and Sonnenberg A: Risk factors of colorectal cancer in inflammatory bowel disease. The American Journal of Gastroenterology 91, 44, 1996.
  • Balog CI, Stavenhagen K, Fung WL, Koeleman CA, McDonnell LA, et al.: N-glycosylation of colorectal cancer tissues: a liquid chromatography and mass spectrometry-based investigation. Molecular & Cellular Proteomics 11, 571–585, 2012.
  • Ullman TA and Itzkowitz SH: Intestinal inflammation and cancer. Gastroenterology 140, 1807–1816, 2011.
  • Sekirov I, Russell SL, Antunes LCM, and Finlay BB: Gut microbiota in health and disease. Physiological Reviews 90, 859–904, 2010.
  • Chen K, Huang J, Gong W, Iribarren P, Dunlop NM, et al.: Toll-like receptors in inflammation, infection and cancer. International Immunopharmacology 7, 1271–1285, 2007.
  • Tsan MF: Toll-like receptors, inflammation and cancer. Seminars in Cancer Biology 16, 32–37, 2006.
  • Yew KH, Carpenter C, Duncan RS, and Harrison CJ: Human cytomegalovirus induces TLR4 signaling components in monocytes altering TIRAP, TRAM and downstream interferon-beta and TNF-alpha expression. PLoS One 7, e44500, 2012.
  • Buchholz BM and Bauer AJ: Membrane TLR signaling mechanisms in the gastrointestinal tract during sepsis. Neurogastroenterology & Motility 22, 232–245, 2010.
  • Schottelius A and Dinter H: Cytokines, NF–κB, microenvironment, intestinal inflammation and cancer. Cancer Treatment and Research 130, 67–87, 2006.
  • Goel GA, Kandiel A, Achkar JP, and Lashner B: Molecular pathways underlying IBD-associated colorectal neoplasia: therapeutic implications. The American Journal of Gastroenterology 106, 719–730, 2011.
  • Pan MH, Lai CS, Wu JC, and Ho CT: Molecular mechanisms for chemoprevention of colorectal cancer by natural dietary compounds. Molecular Nutrition & Food Research 55, 32–45, 2011.
  • Tak PP and Firestein GS: NF-kappaB: a key role in inflammatory diseases. Journal of Clinical Investigation 107, 7–12, 2001.
  • `Annema N, Heyworth JS, McNaughton SA, Iacopetta B, and Fritschi L: Fruit and vegetable consumption and the risk of proximal colon, distal colon, and rectal cancers in a case-control study in Western Australia. Journal of the American Dietetic Association 111, 1479–1490, 2011.
  • Kyrø C, Skeie G, Loft S, Overvad K, Christensen J, et al.: Adherence to a healthy Nordic food index is associated with a lower incidence of colorectal cancer in women: the Diet, Cancer and Health cohort study. British Journal of Nutrition 109, 920–927, 2013.
  • McGhie TK, Hudault S, Lunken RC, and Christeller JT: Apple peels, from seven cultivars, have lipase-inhibitory activity and contain numerous ursenoic acids as identified by LC-ESI-QTOF-HRMS. Journal of Agricultural and Food Chemistry 60, 482–491, 2012.
  • Charde MS, Ahmed A, and Chakole R: Apple phytochemicals for human benefits. 1, 40–55, 2012.
  • Barth SW, Faehndrich C, Bub A, Watzl B, Will F, et al.: Cloudy apple juice is more effective than apple polyphenols and an apple juice derived cloud fraction in a rat model of colon carcinogenesis. Journal of Agricultural and Food Chemistry 55, 1181–1187, 2007.
  • Liu L, Li YH, Niu YB, Sun Y, Guo ZJ, et al.: An apple oligogalactan prevents against inflammation and carcinogenesis by targeting LPS/TLR4/NF-κB pathway in a mouse model of colitis-associated colon cancer. Carcinogenesis 31, 1822–1832, 2010.
  • Li Y, Mei L, Niu Y, Sun Y, Huang H, et al.: Low molecular weight apple polysaccharides induced cell cycle arrest in colorectal tumor. Nutrition and Cancer 64, 439–463, 2012.
  • Fukata M, Chen A, Vamadevan AS, Cohen J, Breglio K, et al.: Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology 133, 1869–1869, 2007.
  • Gerhauser C: Cancer chemopreventive potential of apples, apple juice, and apple components. Planta Medica 74, 1608, 2008.
  • Satahoo SS, Brathwaite C, Davis JS, and Burnweit C: Obstructing apple core lesion of the rectum: a case report of inflammatory pseudotumor masquerading as colorectal carcinoma. Journal of Pediatric Surgery 48, 677–680, 2013.
  • Standiford LR, Standiford TJ, Newstead MJ, Zeng X, Ballinger MN, et al.: TLR4-dependent GM-CSF protects against lung injury in Gram-negative bacterial pneumonia. American Journal of Physiology: Lung Cellular and Molecular Physiology 302, L447–L454, 2012.
  • Triantafilou M and Triantafilou K: Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends in Immunology 23, 301–304, 2002.
  • Zhang J, Kumar A, Wheater M, and Yu FSX: Lack of MD-2 expression in human corneal epithelial cells is an underlying mechanism of lipopolysaccharide (LPS) unresponsiveness. Immunology and Cell Biology 87, 141–148, 2008.
  • Kim SJ, Park HJ, Shin HJ, Shon DH, Kim DH, et al.: Suppression of TRIF-dependent signaling pathway of toll-like receptors by allyl isothiocyanate in RAW 264.7 macrophages. International Immunopharmacology 13, 403–407, 2012.
  • Maldonado ME, Bousserouel S, Gossé F, Lobstein A, and Raul F: Implication of NF-κB and p53 in the expression of TRAIL-death receptors and apoptosis by apple procyanidins in human metastatic SW620 cells. Biomédica 30, 577–586, 2010.
  • Haidl ID, McAlpine SM, and Marshall JS: Enhancement of mast cell IL-6 production by combined toll-like and nucleotide-binding oligomerization domain-like receptor activation. International Archives of Allergy and Immunology 154, 227–235, 2011.
  • Vaiopoulos AG, Papachroni KK, and Papavassiliou AG: Colon carcinogenesis: Learning from NF-κB and AP-1. The International Journal of Biochemistry & Cell Biology 42, 1061–1065, 2010.
  • Kawai T and Akira S: Signaling to NF-[kappa] B by Toll-like receptors. Trends in Molecular Medicine 13, 460–469, 2007.
  • Yamamoto M, Sato S, Hemmi H, Uematsu S, Hoshino K, et al.: TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nature Immunology 4, 1144–1150, 2003.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.